碳青霉烯酶：给儿科传染病专家的简要综述 - Suppr

Suppr

超能文献

Carbapenemases: a brief review for pediatric infectious disease specialists.

作者信息

Overturf Gary D

机构信息

Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.

出版信息

Pediatr Infect Dis J. 2010 Jan;29(1):68-70. doi: 10.1097/INF.0b013e3181c9c118.

DOI:10.1097/INF.0b013e3181c9c118

PMID:20035208

Abstract

摘要

相似文献

Carbapenemases: a brief review for pediatric infectious disease specialists.

Pediatr Infect Dis J. 2010 Jan;29(1):68-70. doi: 10.1097/INF.0b013e3181c9c118.

The emerging threat of acquired carbapenemases in Gram-negative bacteria.

Clin Microbiol Infect. 2010 Feb;16(2):99-101. doi: 10.1111/j.1469-0691.2009.03114.x.

Emerging carbapenemases: a global perspective.

Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S8-14. doi: 10.1016/S0924-8579(10)70004-2.

[Broad-spectrum beta-lactamases in Gram-negative bacteria].

Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2741-5.

Acquired metallo-beta-lactamases: an increasing clinical threat.

Clin Infect Dis. 2005 Dec 1;41(11):1557-8. doi: 10.1086/497839. Epub 2005 Oct 31.

High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.

Indian J Med Microbiol. 2010 Jul-Sep;28(3):267-8. doi: 10.4103/0255-0857.66479.

Parenteral carbapenems.

Clin Microbiol Infect. 2008 Jan;14 Suppl 1:175-80. doi: 10.1111/j.1469-0691.2007.01868.x.

Extended-spectrum beta-lactamases: a brief clinical update.

Pediatr Infect Dis J. 2011 Dec;30(12):1092-3. doi: 10.1097/INF.0b013e31823c0e9d.

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

Clin Microbiol Infect. 2010 Feb;16(2):102-11. doi: 10.1111/j.1469-0691.2009.03115.x.

Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.

Urol Clin North Am. 2015 Nov;42(4):493-505. doi: 10.1016/j.ucl.2015.05.005. Epub 2015 Jul 15.

引用本文的文献

Molecular epidemiology of carbapenem-resistance plasmids using publicly available sequences.

Genome. 2019 Dec;62(12):785-792. doi: 10.1139/gen-2019-0100. Epub 2019 Sep 6.

Carbapenem Resistance: A Review.

Med Sci (Basel). 2017 Dec 21;6(1):1. doi: 10.3390/medsci6010001.

Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6234-43. doi: 10.1128/AAC.00633-16. Print 2016 Oct.

Overexpression of an outer membrane protein associated with decreased susceptibility to carbapenems in Proteus mirabilis.

PLoS One. 2015 Mar 10;10(3):e0120395. doi: 10.1371/journal.pone.0120395. eCollection 2015.

Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.

J Antibiot (Tokyo). 2015 Feb;68(2):115-20. doi: 10.1038/ja.2014.119. Epub 2014 Sep 3.

Crystallization and preliminary diffraction studies of GIM-1, a class B carbapenem-hydrolyzing β-lactamase.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1226-8. doi: 10.1107/S1744309112035695. Epub 2012 Sep 28.

A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital.

Indian J Med Res. 2012 Jun;135(6):907-12.

Modified Hodge test: A simple and effective test for detection of carbapenemase production.

Iran J Microbiol. 2011 Dec;3(4):189-93.

Antibiotic therapy in neonatal and pediatric septic shock.

Curr Infect Dis Rep. 2011 Oct;13(5):433-41. doi: 10.1007/s11908-011-0197-5.

Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France.

J Clin Microbiol. 2011 Aug;49(8):3085-7. doi: 10.1128/JCM.00540-11. Epub 2011 Jun 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验